Close Menu
Home » Data Point to Regulus Alport Drug Use in Late-stage Disease, Other Kidney Diseases

Data Point to Regulus Alport Drug Use in Late-stage Disease, Other Kidney Diseases

Nov 24, 2014
|
staff reporter
Premium

NEW YORK (GenomeWeb) ― Researchers from Sanofi recently reported preclinical data showing that Regulus Therapeutics' microRNA-21 inhibitor RG-012 can have a therapeutic benefit even in the late stages of Alport syndrome and that it can enhance the effect of the kidney protectant ramipril.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

You may already have institutional access!

Check if I qualify.

Already a GenomeWeb or 360Dx Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

The Scan

From the Depths

Researchers have sequenced the genome of the depth-dwelling giant squid.

Not the Research Topic

Prosecutors have charged a former Drexel University professor with theft for allegedly spending federal grant money on adult entertainment and other unrelated expenses, according to the Philadelphia Inquirer.

 

Prison in Insider Trading Case

Chris Collins, a former US representative, has been sentenced to more than two years in prison in an insider trading case involving an Australian biotechnology firm, the New York Times reports.

PNAS Papers on Trypanosoma brucei Transcripts, Inherited Retinal Disease, Gut Microbiome Development

In PNAS this week: Trypanosoma brucei transcripts, estimate of people at risk of inherited retinal disease, and more.

Feb
05
Featured Webinar

Development of a Novel Multiplex Assay: A Partnership Case Study

Sponsored by
LGC

This webinar will provide a behind-the-scenes look at the collaborative development of a novel multiplex assay to speed detection of mosquito-borne illness in the clinical setting.

Feb
20
Featured Webinar

Advances in NGS Gene Expression Studies to Reduce The Cost of Sequencing

Sponsored by
Thermo Fisher Scientific

This webinar will discuss the use of 3’ mRNA sequencing to reduce the cost of gene expression studies on Illumina NGS systems.

Feb
26
Featured Webinar

Transformation of the Lab to Fight Genetic Illnesses in the Amish and Mennonite Populations

Sponsored by
Autogen

This webinar will explain how the Clinic for Special Children in Strasburg, Pennsylvania, has transformed its DNA workflows to improve the diagnosis and treatment of genetic illnesses that are prevalent in the pediatric population of its community.

What's Popular?

In Gene Silencing/Gene Editing

  1. Revocation of Broad Institute CRISPR Patent Upheld in Europe

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2020 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.